Dilemmas in Secondary Stroke Prevention.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 40255157.
- Also identified by DOI 10.1161/STROKEAHA.124.050403.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Secondary stroke prevention encompasses many approaches, including antithrombotic therapy, risk factor management, and a healthy lifestyle. Recommendations are typically based on the results of randomized clinical trials that provide evidence of benefit. However, in some situations, clinicians extrapolate the results of clinical trials into everyday practice, or trials have not provided sufficient information to make treatment decisions. This review will discuss 4 scenarios: dual-antiplatelet therapy, the perils of combining antiplatelet and anticoagulation, indications for statin therapy, and therapeutic considerations for patients with paroxysmal atrial fibrillation.
Medical subject headings
- Stroke
- Secondary Prevention
- Platelet Aggregation Inhibitors